Skip to content
The Nexus
DossierENTITY

PCSK9 Inhibitor

Coverage of PCSK9 Inhibitor in the Nexus archive.

Earliest in view: Jul 16 · 15:28 UTCMost recent: Jul 16 · 15:28 UTC
Co-mentioned in this coverage
Merckorganization1FDAorganization1Lipfendratopic1Statinstopic1
Recent coverage
  • HEALTHJul 16 · 15:28 UTCGUARDIAN US
    Drugmaker Merck announces approval of new cholesterol-fighting drug

    Merck received FDA approval for Lipfendra, a PCSK9 inhibitor that serves as an alternative to statins for managing high LDL cholesterol. Statins, while widely prescribed, can cause side effects like muscle aches and may not sufficiently lower cholesterol levels for some patients.

PCSK9 Inhibitor · Dossier · The Nexus